Articles

The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis.

Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX.
Georgia Cancer Center at Augusta University (research performed while at MD Anderson Cancer Center)
Haematologica Early view Sep 14, 2020 https://doi.org/10.3324/haematol.2020.260125